期刊文献+

早产儿慢性肺疾病的高危因素和预后分析 被引量:4

Analysis on the risk factors and the prognosis of chronic lung disease in premature infants
原文传递
导出
摘要 目的探讨早产儿慢性肺疾病(CLD)的患病危险因素及预后分析。方法统计我院新生儿重症监护病房(NICU)12年间收治的CLD患儿,总结患儿的出生体重、性别、有否围生期窒息、孕周、原发疾病、机械通气时间、用氧浓度、吸气峰压、呼吸暂停、并发症及预后。结果(1)12年间NICU收治的922例早产儿中,发生CLD52例,发生率为5.64%。出生体重1501~2500g早产儿、极低出生体重儿(1001~1500g)和超低出生体重儿(≤1000g)CLD发生率分别为2.37%、12.09%和23.52%.有非常显著性差异(x。=42.92,P〈0.01)。(2)出生体重≤1500g.有围生期窒息,胎龄≤32周,呼吸窘迫综合征机械通气,吸氧浓度≥60%,动脉导管未闭,呼吸暂停,气胸,感染是CLD的高危因素。而性别,吸气峰压与CLD无明显关系。结论早产儿CLD是由多种因素所致,需综合治疗。 Objective To explore the risk factors and prognosis of chronic lung disease(CLD) in preterm infants, Methods Preterm infants with CLD hospitalized in our NICU from July, 1993 to June, 2005 were analyzed retrospectively. Data for review included birth weight, sex, neonatal asphyxia, gestational age, primary disease, ventilation support times, FiO2, PIP, apnea, comorbidity and prognosis. Results ( 1 )The total number of the preterm infants was 922 during 12 years. There were 52 CLD and the morbidity rate was 5.64% .The CLD rate of premature infants with birth weight 1 501-2 500 g, 1 001-1 500 g, ≤1 000 g were 2.37 %, 12.09 % and 23.52 % respectively. There was significant difference in the 3 groups, (2)The incidence of CLD is comparatively high in premature infants with the following characterlstics:blrth weight less than 1 500 g, neonatal asphyxia, gestational age less than 32 weeks, RDS, ventilation support, FiO2≥60 %, PDA, apnea, pneumothorax and lung infection. Conclusion Multiple factors contribute to CLD, thus comprehensive therapy is necessary.
出处 《中国小儿急救医学》 CAS 2006年第4期356-359,共4页 Chinese Pediatric Emergency Medicine
关键词 早产儿 慢性肺疾病 Premature infant Chronic lung disease
  • 相关文献

参考文献13

  • 1Nievas FF,Chernick V.Bronchpulmonary dysplasia(Chronic lung disease of infancy):an update for the pediatrician[J].Clin Pediatr,2002,41(2):77-85.
  • 2Avery GB,Fletcher MA,MacDonald MG.Neonatology pathophysiology & management of the newborn[M].5th Ed.Philadelphia:Lippincott Willimams & wilkins,1999.509.
  • 3Coalson JJ.Pathology of new bronchopulmonary dysplasia[J].Semin Neonatol,2003,8(1):73-81.
  • 4Reese HC,Dale RG,Alan HJ,et al.Lung injury in neonates:Cause,strategies for prevention,and long-term consequences[J].J Pediatr,2001,139(4):478-486.
  • 5Charafeddine L,Angio CT,Phelps DL.Atypical chronic lung disease patterns in neonates[J].Pediatrics,1999,103(4):759-765.
  • 6Sahni R,Ammari A,Suri MS,et al.Is the new definition of bronchopulmonary dysplasia more useful[J].perinatol,2005,25:41-46.
  • 7Speer CP.Inflammation and bronchopulmonary dysplasia[J].Semin Neonatol,2003,8(1):29-38.
  • 8戎群芳,黄绮薇,张国琴.早产儿慢性肺部疾病诊治新进展[J].新生儿科杂志,2005,20(1):44-46. 被引量:1
  • 9Hallman M,Aikio O,Glumoff V,et al.Infection,Respiratory distress syndrome and chronic lung disease-paradoxical roles of inflammatory mediators[J].Bio Neonate,2002,82:287-288.
  • 10Bancalari E.Changes in the pathogenesis and prevention of chronic lung disease of prematurity[J].Am J Perinatol,2001,18(1):1-9.

二级参考文献19

  • 1Hansen T, Corbet A. Chronic lung disease. In Taeusch HW,Ballard RA. Avery's diseases of the newborn. 7th ed. Harcourt Publishers Limited, 2001,634 - 647.
  • 2Nievas FF, Chemick V. Bronchopulmonary dysplasia(Chronic lung disease of infancy) : an update for the pediatrician. Clin Pediatr, 2002,41(2) :77 - 85.
  • 3Jobe AH, Bancalari E. NICHD/NHLBI/ORF workshop summary: bronchopulmonary dysplasia. Am J Respir Crit Care Med,2001,163 : 1723 - 1729.
  • 4Rojas MA, Gonzalez A, Bancalari E, et al. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr, 1995,126:605- 610.
  • 5Zimmerman JJ. Bronchoalveolar inflammatory pathophysiology of bronchopulmonary dysplasia. Clin perinatol, 1995,22: 429-456.
  • 6Speer CP. Pre-and post-natal inflammatory eveaats in chronic lung disease of preterm infants. Acta phamacol sin, 2002, 23:29 - 32.
  • 7Jobe AH. Antenatal factors and the devdopment of bronchop-ulmonary dysplasia. Semin Neonatol, 2003,8(1): 9-17.
  • 8Speer CP. Inflammation and bronchopulmonary dysplasia. Semin Neonatol, 2003,8(1) :29 - 38.
  • 9Welty SE. Is there a role for antioxldant therapy in bronchopuimonary dysplasia? J Nutr,2001,131 (3) :947S - 950S.
  • 10Prandota J. Furosemide: progress in understanding its diuret-ic, anti - inflanmmtory, and bronchodilating mechanism of action, and use in the treatment of respiratory tract diseases. Am J Ther. 2002, 9(4) :317 - 328.

同被引文献41

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部